TORONTO--(BUSINESS WIRE)--May 2, 2006--IntelliPharmaCeutics Corp., a Canadian specialty pharmaceutical company, the operating affiliate of IntelliPharmaCeutics Ltd., (Delaware), is pleased to announce that it has entered into a new agreement with Larasan Pharmaceutical Corporation, a Florida corporation, for the development of a controlled release analgesic product for the United States and worldwide markets.
